Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015- Iftakhar Ahmed Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper publication for postal ballot notice Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Intimation about launch of postal ballot to seek shareholders approval for appointment of Independent Director, Managing Director and Group CEO and Executive Director Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of LOC - Inderpreet Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI(Listing Obligation and Disclosure Requirements) Regulation, 2015 - Vibhishanan V Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Retirement
Intimation under Regulation 30 for completion of tenure of Mr. Bharat Shah as Independent Director of the Company Strides Pharma Science Ltd - 532531 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31, 2024
Strides Pharma Q4 Results Review - Traction In U.S. Building Up: ICICI Securities
gSuprep launch in U.S. and traction in emerging markets drives beat in margin Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Call held on May 22, 2024